Brain proton magnetic resonance spectroscopy in Alzheimer disease: Changes after treatment with xanomeline

American Journal of Geriatric Psychiatry

Volumn 10, Issue 1, 2002, Pages 81-88

  Frederick, Blaise DeB ^a   Satlin, Andrew ^a   Wald, Lawrence L ^a   Hennen, John ^a   Bodick, Neil ^a   Renshaw, Perry F ^a  

^a MCLEAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; CHOLINE; CREATININE; PLACEBO; XANOMELINE;

ALZHEIMER DISEASE; AMNESIA; ARTICLE; COGNITION; DISEASE COURSE; GRAY MATTER; HUMAN; PARIETAL LOBE; PATIENT MONITORING; PROTON NUCLEAR MAGNETIC RESONANCE; TREATMENT OUTCOME;

EID: 0036143544     PISSN: 10647481     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019442-200201000-00010     Document Type: Article

References (15)

1. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia
2. "Autocannibalism" of cholinecontaining membrane phospholipids in the pathogenesis of Alzhemer's disease: A hypothesis
3. Increased glycerol-3-phosphorylcholine in postmortem Alzheimer's brain
4. Evidence for a membrane defect in Alzheimer's disease brain
5. Choline metabolism as a basis for the selective vulnerability of cholinergic neurons
6. 1 selective cholinergic agonist
7. A new rating scale for Alzheimer's disease
8. Quantitative proton spectroscopy of canine brain: In vivo and in vitro correlations
9. Routine quantitative analysis of brain and cerebrospinal fluid spaces with MR imaging
10. Removal of the water resonance from IH magnetic resonance Spectra
11. Application of time-domain fitting in the quantification of in vivo 1H spectroscopic imaging data sets
12. Magnetic resonance spectroscopy in dementia
13. Prediction of cognitive decline in early Alzheimer's disease